21 Mar. 2018

Maria Rescigno

Gut-liver axis
Hosted by Agustín Albillos

  • Wednesday, 21st
  • 16h / IiSGM
  • MAD



March seminar will cover the topic of Gut-Liver axis and the role of Dendritic cells in this pathological cross-talk.


Visits will always have the same agenda: during the morning, the Expert will be able to meet in private with scientists from research centres geographically close to the Institution that welcomes him (please book your time slot at the “meet the speaker” tab), in the afternoon we will have the seminar itself that will be live broadcasted to the Institute that does not host the speaker.

Please note that activities are not restricted to the personnel from the organizing institutions. In this page you will find detailed information about the invited Speakers and scientific topics that will be covered during this academic year.

  • 9:00-10:00 SLOT TIME ALREADY BOOKED Maria Rescigno
  • 10:00-11:00 SLOT TIME ALREADY BOOKED Maria Rescigno
  • 11:00-12:00 SLOT TIME ALREADY BOOKED Maria Rescigno
  • 12:00-13:00 SLOT TIME ALREADY BOOKED Maria Rescigno

Maria Rescigno

Maria Rescigno is the Director of Experimental Oncology Unit on Dendritic cell biology and Immunotherapy at the European Oncology Institute in Milan. She obtained her PhD at the University of Milan and has been visiting scientist at the University of Cambridge (1991-1994) and visiting Professor at the University of Oslo (2007-2012). Her research field focuses on the study of dendritic cell biology in the mucosal immune system with particular emphasis on cancer immunotherapy. Dr Rescigno is an EMBO member, received successive funding from the ERC, and published over 90 papers being most of them in top-rated journals including Nature, Nature Medicine and Science.


Find below the video recording as soon as it is available.


The LiverSeminars Program is distributed along the 2019/2020 academic year. Find herein the upcoming seminars.


The LiverSeminars Program is possible thanks to the support from these private and public entities.